(Q51019962)
Statements
The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer. (English)
1 reference
Peggy Manders
1 reference
Vivianne C G Tjan-Heijnen
1 reference
Paul N Span
1 reference
Nicolai Grebenchtchikov
1 reference
Anneke J Geurts-Moespot
1 reference
Doorléne T H van Tienoven
1 reference
Louk V A M Beex
1 reference
Fred C G J Sweep
1 reference
1 March 2004
1 reference
91
1 reference
3
1 reference
514-521
1 reference